Resources Contact Us Home
Intracorporeal medicaments for photodynamic treatment of disease

Image Number 3 for United States Patent #7863047.

New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection. In another preferred embodiment, such medicaments are produced in various formulations including liquid, semisolid, solid or aerosol delivery vehicles.

  Recently Added Patents
Processing of matching regions in a stream of screen images
Cargo netting system
Zero-knowledge based authentication method, system, and apparatus
Method for fabricating light guide plate
Method for determining transmission channels for a LPG based vehicle communication network
Thermally treated ceramic coating for implants
Micro-actuator enabling single direction motion of a magnetic disk drive head
  Randomly Featured Patents
Superabsorbent polymer foam
Imaging methods
Speed ratio shift method
Method for decreasing nicotine and other substance use in humans
Silver halide color photosensitive material
Solar cell with two-dimensional reflecting diffraction grating
Thermal imaging processes and products of electroactive organic material
Plants and seeds of corn variety CV520536